SEC Filings for Aridis Pharmaceuticals Inc. (ARDS)

$ 8.40 0.00 (0.00%) Volume: 1.54k 4:00 PM EDT 26-May-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
424B5Prospectus [Rule 424(b)(5)]105/14/2020
8-KCurrent report pursuant to Section 13 or 15(d)1005/12/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)3605/12/2020
8-KCurrent report pursuant to Section 13 or 15(d)1105/05/2020
DEF 14AOther definitive proxy statements4504/17/2020
10-KAnnual report pursuant to Section 13 or 15(d)18104/08/2020
8-KCurrent report pursuant to Section 13 or 15(d)1104/08/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans904/08/2020
4Statement of changes in beneficial ownership of securities104/06/2020
NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405203/30/2020
8-KCurrent report pursuant to Section 13 or 15(d)503/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)503/05/2020
8-KCurrent report pursuant to Section 13 or 15(d)603/04/2020
8-KCurrent report pursuant to Section 13 or 15(d)601/28/2020
4Statement of changes in beneficial ownership of securities101/13/2020
<<
First
<
Prev
12345678